Anti-TNFα agents safe, effective in steroid-refractory microscopic colitis
Treatment with vedolizumab and antitumour necrosis factor-α agents provides clinical benefits, with an acceptable safety profile, in patients with steroid-refractory microscopic colitis (MC), suggests a study.
Anti-TNFα agents safe, effective in steroid-refractory microscopic colitis
13 Sep 2024